OMNIOX, INC

Basic Information

75 SHOREWAY RD STE A
SAN CARLOS, CA, 94070-2727

Company Profile

n/a

Additional Details

Field Value
DUNS: 786563036
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 21


  1. Chemosensitizing Hypoxic Multiple Myeloma With Tunable, Long-Lived Oxygen Carriers

    Amount: $280,141.00

    DESCRIPTION provided by applicant Hypoxia is a well characterized driver of solid tumor metastasis and recent clinical evidence in the blood cancer multiple myeloma MM has uncovered a major role ...

    SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
  2. Engineering of human H-NOX as an oxygen delivery therapeutic for prolonged admini

    Amount: $225,000.00

    Engineering'of'Human'H.NOX'as'an'Oxygen'Delivery'Therapeutic'for'Prolonged'Administration' ' ' Project Summary/Abstract Omniox has ...

    SBIR Phase I 2014 Department of Health and Human Services
  3. TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUTRAL, TUNABLE OXYGEN-BINDING PRO

    Amount: $1,000,000.00

    PROJECT SUMMARY/ABSTRACT Through Phase I and II SBIR NCI support, Omniox has developed a breakthrough oxygen carrying protein, OMX-4.80, that delivers oxygen to tumors and greatly reduces hypoxia. Th ...

    SBIR Phase II 2012 Department of Health and Human Services
  4. Improving Chemotherapy with a Novel Oxygen-Delivery Protein

    Amount: $300,000.00

    Omniox has identified a breakthrough tunable oxygen (O2) delivery technology that perfuses deep into tumors and eliminates hypoxia. Hypoxia, a prominent feature in solid tumors, affects multiple cha ...

    SBIR Phase I 2012 Department of Health and Human Services
  5. Reducing Brain Injury After Focal Ischemia Using a Nitric Oxide-Neutral Oxygen Ca

    Amount: $274,359.00

    DESCRIPTION (provided by applicant): Omniox is developing a new oxygen delivery therapeutic (H-NOX) that has the potential to dramatically reduce the damage associated with stroke. Stroke causes the l ...

    SBIR Phase I 2012 Department of Health and Human Services
  6. TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUTRAL, TUNABLE OXYGEN-BINDING PRO

    Amount: $3,067,900.00

    DESCRIPTION (provided by applicant): Low oxygen conditions (hypoxia) commonly found in solid tumors are considered a major obstacle for the clinical management of cancer by radiation therapy (radiothe ...

    SBIR Phase II 2010 Department of Health and Human Services
  7. Targeted Oxygen Delivery to Wounds: Using a Novel, Tunable, Oxygen Delivery Tech

    Amount: $331,743.00

    DESCRIPTION (provided by applicant): This project will develop a novel class of oxygen binding proteins (H-NOX proteins) as a topical treatment for chronic wounds. These proteins are designed to p ...

    SBIR Phase I 2010 Department of Health and Human Services
  8. TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUTRAL, TUNABLE OXYGEN-BINDING PRO

    Amount: $480,058.00

    DESCRIPTION (provided by applicant): Low oxygen conditions (hypoxia) commonly found in solid tumors are considered a major obstacle for the clinical management of cancer by radiation therapy (radiothe ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government